In the News
In March 2023, Michigan Retina Center will be offering the first ever FDA approved treatment for Geographic Atrophy caused by Advanced Dry Macular Degeneration - SYFOVRE.
Published Book Chapter
In 2021, Dr. Tewari published a chapter in "Cutting-edge Vitreoretinal Surgery" (Springer).
Retina Society 2021
Dr. Tewari presented on new cannula design in small gauge vitrectomy at The Retina Society in Chicago, Illinois in September 2021.
Proven to be reliable and safe, TissueBlue™ is the only FDA-approved selective stain for removal of the Internal Limiting Membrane (ILM). In this high-resolution video below, watch Dr. Tewari demonstrate use of this stain during the delicate process of vitreoretinal surgery.
See Dr. Tewari in action during surgery.
Our new intraoperative OCT (iOCT) technology enables us to utilize "real-time" imaging during vitreo-retinal surgery. This state-of-the-art system allows us to visualize the retinal surface while performing surgery. This technology is available in only a handful of institutions in the world and we are fortunate to be able to use this routinely on all of our surgical cases.
In addition to iOCT, we use a 3D Digital-Assisted Vitrectomy HD System (Ngenuity), which creates an overall increase in magnification and better depth of field during surgery compared to traditional microscopes.
3D Surgery with intraoperative
OCT at work
Global Retina Health Initiative
Michigan Retina Center founded the Global Retina Health Initiative, a 501(c)(3) nonprofit organization. The Global Retina Health Initiative aims to advance retinal health worldwide and accomplishes this goal by:
Conducting educational seminars
Providing diagnostic equipment to underserved areas
Supporting physicians who do not have adequate access to the tools and funding for research of retinal diseases
Your support makes a difference in improving retina health worldwide.
For more information:
Visit us at GlobalRetinaHealth.org
Contact us at Info@GlobalRetinaHealth.org